Cargando…

The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety

Anxiety affects over 260 million people worldwide. Benzodiazepines are a class of agents used in combination with other therapies for the management of anxiety. Lorazepam is a commonly prescribed benzodiazepine metabolized by uridine 5’-diphosphate-glucuronosyltransferases. Herein, we discuss recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ching, Nathan R, Alzghari, Amna K, Alzghari, Saeed K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2018
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235651/ https://www.ncbi.nlm.nih.gov/pubmed/30443442 http://dx.doi.org/10.7759/cureus.3133

Ejemplares similares

Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
por: Zheng, Connor L, et al.
Publicado: (2018)

An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity
por: Alzghari, Saeed K
Publicado: (2018)

Proposal for a Pharmacogenetic Decision Algorithm
por: Alzghari, Saeed K, et al.
Publicado: (2017)

The Current Landscape of Marijuana and Pharmacogenetics
por: Rambaran, Kerry Anne, et al.
Publicado: (2017)

Pain Perception and the Opioid Receptor Delta 1
por: Hilgemeier, Adam T, et al.
Publicado: (2018)

Role of the UGT2B17 deletion in exemestane pharmacogenetics
por: Luo, Shaman, et al.
Publicado: (2017)

The Road to a Hypoglycemic Care Model
por: Moore, Markus, et al.
Publicado: (2019)

Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
por: Alzghari, Saeed K., et al.
Publicado: (2020)

Gamer's Thrombosis: A Review of Published Reports
por: Rambaran, Kerry Anne, et al.
Publicado: (2020)

Pharmacogenetics of ugt genes in North African populations
por: Gaibar, M., et al.
Publicado: (2018)

Systematic review of the clinical consequences of butyrfentanyl and corresponding analogues
por: LE, Alexander Dinh, et al.
Publicado: (2019)

Evaluation of Factors which Influence Mortality in Gram-positive Bacteremia in Hemodialysis Patients
por: Rambaran, Kerry Anne, et al.
Publicado: (2018)

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015)

Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
Publicado: (2015)

Treating Non-fentanyl-derived Synthetic Opioid Overdose with a Traditional Opioid Reversal Agent
por: Acuna, Valerie S, et al.
Publicado: (2020)

A Review of the Opioid Analgesic Benzhydrocodone-Acetaminophen
por: Mustafa, Ahmaya A, et al.
Publicado: (2018)

Pharmacogenetics of uridine diphosphate glucuronosyltransferase (UGT2B7) genetic polymorphism on valproic acid pharmacokinetics in epilepsy
por: Munisamy, Murali, et al.
Publicado: (2014)

Pharmacogenetics of Statin-Induced Myotoxicity
por: Kee, Ping Siu, et al.
Publicado: (2020)

To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates
por: Alzghari, Saeed K, et al.
Publicado: (2017)

LORAZEPAM FOR ALCOHOL WITHDRAWAL
por: Andrade, Chittaranjan
Publicado: (2003)

Lorazepam-induced diplopia
por: Lucca, Jisha M., et al.
Publicado: (2014)

Pharmacogenetics of CYP2A6, CYP2B6, and UGT2B7 in the Context of HIV Treatments in African Populations
por: Ford, Graeme R., et al.
Publicado: (2022)

Molecular Mechanism of the UDP-Glucuronosyltransferase 2B20-like Gene (AccUGT2B20-like) in Pesticide Resistance of Apis cerana cerana
por: Cui, Xuepei, et al.
Publicado: (2020)

Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019)

Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
por: Le, Alexander D, et al.
Publicado: (2017)

Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships
por: Saugstad, Austin A., et al.
Publicado: (2022)

The clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactions
por: Marques, Sara Correia, et al.
Publicado: (2010)

Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
por: de With, Mirjam, et al.
Publicado: (2023)

Revisiting Secondary Information Related to Pharmacogenetic Testing
por: Haga, Susanne B.
Publicado: (2021)

Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
por: Bai, Jie, et al.
Publicado: (2019)

Electroconvulsive Therapy in Lorazepam Non-Responsive Catatonia
por: Girish, K., et al.
Publicado: (2003)

UGT1A1 (TA)(n) Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia
por: Vukovic, M, et al.
Publicado: (2018)

CATATONIC SYNDROME : TREATMENT RESPONSE TO LORAZEPAM
por: Payee, Haniya, et al.
Publicado: (1999)

Regulation of Hepatic UGT2B15 by Methylation in Adults of Asian Descent
por: Oeser, Steffen G., et al.
Publicado: (2018)

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial
por: Shah-Williams, Ebony, et al.
Publicado: (2020)

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
por: den Uil, Manon G., et al.
Publicado: (2023)

Methylenetetrahydrofolate Reductase A1298C Polymorphism and Major Depressive Disorder
por: Cho, Kevin, et al.
Publicado: (2017)

On the Horizon: The Synthetic Opioid U-49900
por: Alzghari, Saeed K, et al.
Publicado: (2017)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
por: Lee, Su-Jun
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7apdhgk8ttuq3kj76qvhqj12d1